Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Another approval for Abelcet and further patent coverage

Nov. 1, 1996

Mentax approved for marketing

Nov. 1, 1996

Sankyo prepares pseudomonic acid derivatives

Nov. 1, 1996

Potent antifungal agent described by Morishita Roussel

Nov. 1, 1996

New antibiotic from Sankyo

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Seventeenth approval for Amphocil/Amphotec

Oct. 25, 1996

Key patents issued covering Applied Microbiology's lanthocins

Oct. 25, 1996

Natural antibacterial chitinase inhibitors

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.